GlassScriptPhysician profile
Amy Masowick
NPI 1972828770
$10,485.98
in general payments reported to CMS, 2019-2025
27 companies · $963 in 2025
The $963 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,727 · 2020: $724 · 2021: $715 · 2022: $1,329 · 2023: $4,105 · 2024: $923 · 2025: $963.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,064 · Travel and Lodging: $1,927.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,063.82 |
| Travel and Lodging | $1,927.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $5,450.81 | 2019-2025 | Variax, Augment Injectable, Hoffmann |
| Abbott Laboratories | $2,018.36 | 2019-2023 | Jeti, Diamondback Coronary, Armada |
| Paragon 28, INC. | $483.56 | 2019-2024 | Precision Mis Bunion, Baby Gorilla |
| Medtronic, INC. | $277.98 | 2021-2022 | |
| Wright Medical Technology, INC. | $204.70 | 2019 | |
| Convatec INC. | $189.72 | 2025 | |
| Reflow Medical INC | $180.00 | 2025 | |
| Boston Scientific Corporation | $168.42 | 2020-2023 | |
| Penumbra, INC. | $152.49 | 2025 | Penumbra System |
| Imperative Care, INC | $143.05 | 2023 | Prodigy Catheter |
| Cardiovascular Systems INC. | $138.60 | 2019 | |
| Truvic Medical, INC. | $133.49 | 2022 | |
| Smith+Nephew, INC. | $131.12 | 2019-2025 | Hat-Trick, Na |
| Flower Orthopedics Coporation | $128.07 | 2025 | |
| Bone Support INC. | $115.47 | 2024 | Cerament G, Ceramentbone Void Filler |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $115.12 | 2019 | |
| Bioventus LLC | $96.42 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Paratek Pharmaceuticals, INC. | $81.08 | 2025 | Nuzyra |
| Treace Medical Concepts, INC. | $68.21 | 2022-2023 | |
| Zimmer Biomet Holdings, INC. | $47.22 | 2020-2023 | Juggerknotless Soft Anchor, Stratum Foot Plating System, Genex |
| Legacy Ortho LLC | $39.32 | 2023 | |
| Arteriocyte Medical Systems, INC. | $36.67 | 2025 | Magellan |
| Averitas Pharma INC. | $19.91 | 2024 | Qutenza |
| Nabriva Therapeutics, Plc | $17.33 | 2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $17.28 | 2021 | |
| Amgen INC. | $16.44 | 2024 | Krystexxa |
| Horizon Therapeutics Plc | $15.14 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Masowick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.